chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received vaccine. Within 2 minutes, he felt lightheaded and sweaty. He stood up to go to the observation area. We had him sit-down and place his head lower than his chest. He almost immediately felt better. He had flown in. He mentioned he had not drank much water since, but he had eaten. He was fine after the observation period and left.
rash is about the size of a quarter; tender to touch; rash is hot to touch; This case was reported by a pharmacist and described the occurrence of rash in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number 95JR5, expiry date 5th November 2022) for prophylaxis.   On 13th September 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 14th September 2021, 1 days after receiving Shingrix, the patient experienced rash, tenderness and feeling hot. On an unknown date, the outcome of the rash, tenderness and feeling hot were not recovered/not resolved.   It was unknown if the reporter considered the rash, tenderness and feeling hot to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that patient had received her Shingrix vaccine in the left deltoid and developed the rash which was about the size of a quarter that was lower down the arm from the injection site on the next day in the early morning. The pharmacist reported that the rash was tender and hot to the touch. The reporter consented to follow up.
platelet count 3; purple dots on body; Red dots on body; skin was bleeding; tongue blisters; bruising on body, arm, stomach and legs; did not received 2 dose; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET COUNT DECREASED (platelet count 3) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIUM for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PLATELET COUNT DECREASED (platelet count 3) (seriousness criterion hospitalization). On an unknown date, the patient experienced PURPURA (purple dots on body), ERYTHEMA (Red dots on body), SKIN HAEMORRHAGE (skin was bleeding), TONGUE BLISTERING (tongue blisters), CONTUSION (bruising on body, arm, stomach and legs) and PRODUCT DOSE OMISSION ISSUE (did not received 2 dose). The patient was hospitalized from 14-Apr-2021 to 16-Apr-2021 due to PLATELET COUNT DECREASED. The patient was treated with PREDNISONE at a dose of 20 mg. On 16-Apr-2021, PLATELET COUNT DECREASED (platelet count 3) had resolved. At the time of the report, PURPURA (purple dots on body), ERYTHEMA (Red dots on body), SKIN HAEMORRHAGE (skin was bleeding), TONGUE BLISTERING (tongue blisters) and CONTUSION (bruising on body, arm, stomach and legs) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (did not received 2 dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Platelet count: 3 (Inconclusive) 3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products also included medication for joint pain. Treatment: Prednisone 20 mg for 10 days, but only took two pills. Patient had her first dose of Moderna COVID19 Vaccine on 02Apr2021 in left deltoid. She was scheduled for the second dose on 30Apr2021, but the doctor told her not to go. Nine days after the vaccine, patient had red, purple small dots on her body. It looked like her skin was bleeding. She had blisters on her tongue. She had bruising all over her body: on her arms, stomach, legs. On 14Apr2021, she went to the hospital because her platelet count was 3. She was discharged  16Apr2021.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
A pharmacist reported that a 26-year-old female received an injection of Flu Shield (2001-2002 Formula) on 26-Nov-2001 and the next day, developed an injection site reaction characterized by redness and minor swelling. The patient recovered within 48 hours. The reporter indicated that this event was "possibly due to the reported absence of swabbing injection site prior to vaccine administration. As of the date of this report, no further information was available. This is 1 of 3 patients for this facility to experience an adverse event following receipt of flu shield (2001-2002 formula lot 4018040. See MSNs: HQ9041603DEC2001 and HQ9984821JAN2002
felt a little tired after her first vaccination; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (felt a little tired after her first vaccination) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced FATIGUE (felt a little tired after her first vaccination). At the time of the report, FATIGUE (felt a little tired after her first vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Likely varicella vaccine related. 12 m/o who had a reaction to his vaccines on his leg, area became red, swollen, and itchy. Received MMR, varicella, and hep A in L leg on April 4. Reaction started about 2 wks ago. No fever, no rash. Currently the area looks better but remains itchy. Pt. scratches the area whenever it is exposed. Otherwise feels well.
Headache, Myalgia, Fever, NauseaVomiting, Uncontrolled shivering, fatigue, shortness of breath,soreness at injection site, fever 99.9-103 for 2 days
Nasal congestion, runny nose, facial pressure, slight temp since 12-28-11. Given AMOXIL 875mg BID x 10 days on 1-4-12 for acute sinusitis.
availability issue; This case was reported by a consumer via call center representative and described the occurrence of product availability issue in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 20th June 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced product availability issue. On an unknown date, the outcome of the product availability issue was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. The patient did not receive 2nd dose of shingrix due to availability issue, which led to product availability issue. The reporter consented to follow up with health care professional, however did not have an email address to health care professional.
pt recv vax & states glands in neck & groin started to swell w/in 1wk of vax;states felt lethargy-weakness occasional chills;
Parent reported to MD that child broke out with a rash and had full-blown chickenpox the night of his vaccine administration. This lasted for 2 weeks.
Moderna COVID-19 Vaccine EUA  According to my primary physician, developed angioderma with an accompanying rash a week after receiving the first dose.  He is treating it with antibiotics and steroids. Just starting today so do not know the outcome.  Hopefully it will clear up.
Pt became nauseated and lightheaded. Pt vomited x2. Pt stated symptoms improved. Pt declined transport to ED
Anaphylaxis: 0.3mL EPI 1:1 via IM, Benadryl  50mg via IM, Seek Eval at ER.
Pt. was accidentally vaccinated with BOOSTRIX instead of DAPTACEL for a kindergarten physical. Pt. with mother. No reaction noted after staying 15 min. after injection.
Pt. states that after receiving the 3rd dose of Phizer 01/06/2022, started experiencing symptoms that evening of chest pains, shortness of breath, chest pressure, and vertigo. No noted Primary visit/communications. Vertigo and brain fog continuing, chest pressure and heart palpations have subsided.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 17-NOV-2015 at time- 10:56, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 4.1 and 2.9 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
Six hours foloowing the booster the injection site was painful.  Fouteen hours after shot, I felt as though I had been crushed by an elephant!  By10:00 a.m. (the day after the shot) I had a temp of 101.1.  Took ibuprofen  the rest of day... temp lowered to 98.4 and slept well that night.  Next day felt on the mend and pain was lessend with temp ~ 97.7.  As I write this, I have an earache (left) and the roof of my mouth feels burnt... temp 98.1.  Currently taking 200mg ibuprofen every two hours for the shooting pain in the ear.
Discharge Provider: DO Primary Care Provider: NP Admission Date: 10/16/2022 Discharge Date: Oct 20, 2022   PRESENTING PROBLEM: Severe sepsis Pneumonia of right lower lobe due to infectious organism Sepsis with acute hypoxic respiratory failure, due to unspecified organism, unspecified whether septic shock present    HOSPITAL COURSE: Patient is a 97-year-old gentleman, resident of long-term facility who has been declining over the past several weeks and has become less responsive.  He was diagnosed with COVID-19 and August of 2022.  Past medical history includes chronic atrial flutter, chronic obstructive pulmonary disease, coronary artery disease.  Patient was treated for sepsis and at admission is chest x-ray revealed hazy infiltrate and airspace disease of the right lower lung.  Patient wishes to be made comfortable, no aggressive treatments, no vasopressors cardiac resuscitation, no CPR no BiPAP and no intubation/ventilation were respected.  Patient's family agreed with his wishes to be kept comfortable and allow a natural death. The patient was treated with antibiotics for healthcare associated pneumonia.  He was placed in appropriate isolation precautions.  He was seen by appropriate therapies and care management.  It was felt difficult to advance his antibiotics due to inability to safely swallow.  It was suspected current issues were at least in part related aspiration pneumonia.  Wishes to generally proceed in a comfort oriented treatment plan were respected. The patient was seen by hospice on 10/19/2022 and the outcome of this meeting with family was the desire to return to his place of residence under the care of hospice.  Roxanol was added to his medical regimen.  Arrangements for return to long-term facility under hospice care were made today.  Antibiotics will be discontinued.  Code status at discharge is do not resuscitate.  Prognosis is poor/terminal, family aware.
Agitation, Headache, Myalgia, Angina, anxiety Narrative:
Body aches, rash on arm, lethargy/fatigue, headache.  This was my first shot but I previously had covid. Everything related to baby/fetus is fine. I?m due 7/23/21
Myalgias in bilateral thighs, left shoulder, and right shoulder- Worst at 24 hours later. Headache-24 hours later. Poor thermoregulation with near vasovagal syncope while in the OR-24 hours later.
client's brother called clinic 4/12/19 around 8:40 am.  Stated client woke up 4/12/19 in AM complaining of redness on left arm from elbow to top of arm. States redness is not painful and not itching. Also is complaining of "numbness" down left arm.
felt a discomfort in his groin area; kidney was hurting on his left side; Urinating less and less amounts until I couldn't urinate for 12 hours; Dizziness; faster heart rate; Chills; problems urinating; had the feeling of going to the bathroom even though nothing came out; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), HEART RATE INCREASED (faster heart rate), CHILLS (Chills), MICTURITION DISORDER (problems urinating) and DYSURIA (had the feeling of going to the bathroom even though nothing came out) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ATENOLOL, CLOPIDOGREL BISULFATE (lisinopril), UBIDECARENONE (COQ 10) and CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced DIZZINESS (Dizziness), HEART RATE INCREASED (faster heart rate), CHILLS (Chills), MICTURITION DISORDER (problems urinating), DYSURIA (had the feeling of going to the bathroom even though nothing came out) and OLIGURIA (Urinating less and less amounts until I couldn't urinate for 12 hours). On 21-Feb-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (felt a discomfort in his groin area) and RENAL PAIN (kidney was hurting on his left side). On 21-Feb-2021, MICTURITION DISORDER (problems urinating), DYSURIA (had the feeling of going to the bathroom even though nothing came out) and OLIGURIA (Urinating less and less amounts until I couldn't urinate for 12 hours) had resolved. On 23-Feb-2021, HEART RATE INCREASED (faster heart rate) and CHILLS (Chills) had resolved. On 24-Feb-2021, MUSCULOSKELETAL DISCOMFORT (felt a discomfort in his groin area) had resolved. At the time of the report, DIZZINESS (Dizziness) and RENAL PAIN (kidney was hurting on his left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
24 HOURS AFTER VACCINATION OF BOTH SEQIRUS FLU AND PFIZER COVID-19 ON PATEINTS LEFT ARM PATIENT BROKE OUT IN HIVES AND FIREY TINGLING SENSATION THROUGHOUT BODY. PATIENTS SYMPTOMS PRESISTED SO PATIENT SOUGHT MEDICAL ATTENTION FROM A MEDICAL PROFESSIONAL. PATIENTS SYMPTOMS ARE PRESISITNG BUT TO A LESSER DEGREE.
father in law died; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DEATH (father in law died) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            No concomitant drug was reported.  Reporter stated that the vaccine was full of toxins. There was no data on the effectiveness. Reporter stated that kid's death was up 700%. She stated that people all over the world have died from this injection. She stated that health departments were promoting toxic ingredients. She stated that the injection was murdering kids and adults and everyone in the world.  No Treatment medications were reported.  Company Comment: This spontaneous case concerns a male patient (age not specified) with no medical history reported, who experienced the unexpected Fatal serious (medically significant) event of Death that occurred in the context of mRNA-1273 vaccination. Latency cannot be assessed since vaccination date was not disclosed. Death occurred on an unknown date. The cause of death was not reported. It is unknown if an autopsy was performed. No further details on clinical course, other lab test results and treatment received were reported. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2022-639298, US-MODERNATX, INC.-MOD-2022-639300, US-MODERNATX, INC.-MOD-2022-639230 (E2B Linked Report).; Sender's Comments: This spontaneous case concerns a male patient (age not specified) with no medical history reported, who experienced the unexpected Fatal serious (medically significant) event of Death that occurred in the context of mRNA-1273 vaccination. Latency cannot be assessed since vaccination date was not disclosed. Death occurred on an unknown date. The cause of death was not reported. It is unknown if an autopsy was performed. No further details on clinical course, other lab test results and treatment received were reported. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. US-MODERNATX, INC.-MOD-2022-639298:brother-in law case US-MODERNATX, INC.-MOD-2022-639300:multiple patients invalid case US-MODERNATX, INC.-MOD-2022-639230:mother  in law case; Reported Cause(s) of Death: unknown cause of death
I am 30 weeks pregnant.  Due Sept 25, 2021. I  had pain in left arm of injection. Then the pain started to generate through my  pinky finger and finger next to it.  I waited for it it subside. I had tingling sensation and it still occurs. It sometimes have  a numb like feeling and muscle weakness. I struggle using that hand due to muscle weakness.  I wi drop things often while holding it. I didn't have this issue until after the vaccination.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses of Moderna COVID-19 were administered beyond the beyond use date) and PRODUCT STORAGE ERROR (Vaccine put in the fridge on 30Dec2021 and doses were administered on 11Mar2022) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses of Moderna COVID-19 were administered beyond the beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine put in the fridge on 30Dec2021 and doses were administered on 11Mar2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired doses of Moderna COVID-19 were administered beyond the beyond use date) and PRODUCT STORAGE ERROR (Vaccine put in the fridge on 30Dec2021 and doses were administered on 11Mar2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. It was reported that, the patient received total 3 doses and this was booster dose. On 30-Dec-2021, the vials were initially stored in the refrigerator. The vial did not undergo any temperature excursions. No treatment medications were provided. This case was linked to MOD-2022-584679, MOD-2022-584680 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up information was received includes patient demographics and primary reporter details were updated. New event product storage error was added and event verbatim of expired vaccine used was updated.
Red rash on both upper arms at injection sites, Also same red rash on Left forearm. Pt. And parent state not itchy.
Maternal  exposure during pregnancy; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal  exposure during pregnancy) in a 27-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Emergency C section gestational diabetes for mother  Live, full-term birth) on 12-Feb-2020. Concurrent medical conditions included Asthma. Concomitant products included BUSPIRONE HYDROCHLORIDE (BUSPAR) and ALBUTEROL [SALBUTAMOL] for Asthma, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Vitamin supplementation.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 11-Aug-2021. On 10-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal  exposure during pregnancy). On 10-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal  exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Previous pregnancy end date included 12-Feb-2019 with live birth(emergency c- section -gestational diabetes for mother). Treatment information was not provided.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided. On 31-MAY-2016, the patient was vaccinated with an improperly stored dose of VARIVAX lot # reported as M000995, expiration date reported as 06-JAN-2018 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of -8.4 degrees Celsius for 17.5 hours. There was previous excursion of -8.5 degrees Celsius for 37 hours.  Data logger was involved. This is one of several reports received from the same reporter. Additional information has been requested.
pt recv vax;tonic clonic sz,less than 10 min;hot to touch;fever of 101;still sluggish w/ dec resp;red ear;